IBM Shares Plunge as AI Innovation Threatens Core Business
26.02.2026 - 03:52:59 | boerse-global.deIBM's stock suffered its most severe single-day decline since the year 2000 on February 23, erasing approximately $30 billion in market capitalization within hours. The catalyst for this dramatic sell-off was an announcement from AI startup Anthropic, which introduced new capabilities that directly challenge a fundamental and highly profitable segment of IBM's operations. This event has sparked a fierce debate among investors: is this a sign of structural decline for the legacy tech giant, or merely a market overreaction?
The AI Tool That Rattled Investors
The source of the disruption was a blog post from Anthropic detailing enhancements to its Claude Code AI platform. A key new feature is the tool's ability to automate a significant portion of the modernization process for COBOL, the decades-old programming language that still forms the backbone of countless mainframe systems in global banking and government institutions.
This strikes at the heart of a lucrative revenue stream for IBM. A substantial portion of the company's high-margin mainframe and consulting business is built around maintaining, servicing, and modernizing these legacy systems. The prospect of artificial intelligence efficiently handling such work placed a critical question mark over future earnings from this segment. Investor reaction was swift and severe, driving the share price down by 13.2 percent.
Market Experts See an Exaggerated Response
Following the initial plunge, the stock price showed signs of stabilization. Several financial analysts characterized the sell-off as disproportionate. Their consensus view highlights the inherent complexity of mainframe modernization, arguing it extends far beyond simple code translation. Critical aspects like systems integration, performance optimization, and meeting stringent security protocols continue to demand deep human expertise and oversight.
Furthermore, IBM's large enterprise clients have relied on its platform for decades, a relationship built on unparalleled reliability and security. Migrating away from this ecosystem is widely viewed as a costly, complex, and risky undertaking. Analysts also note that IBM is actively developing its own suite of AI-powered modernization tools. In a notable shift, UBS upgraded its rating on IBM shares from "Sell" to "Neutral" after the decline, citing a more balanced risk-reward profile at the new price level.
Should investors sell immediately? Or is it worth buying IBM?
A Concurrent Narrative: Cybersecurity in the AI Era
Adding a layer of complexity to the story, IBM's security arm, X-Force, released its Threat Intelligence Index 2026 report on February 25. The findings indicate a rising trend of cybercriminals exploiting basic security vulnerabilities, a process increasingly accelerated by the use of AI tools. While this report does not pose an immediate direct threat to IBM's cybersecurity solutions business, its timing underscores the dual-edged nature of artificial intelligence—presenting both significant risks and opportunities for established technology providers.
Currently, IBM shares are trading around €201, which is roughly 26 percent below their 52-week high of €271.80. The company's trajectory now hinges on the speed at which it can advance and deploy its proprietary AI solutions for mainframe modernization, and on whether its long-standing clients will genuinely consider adopting external alternatives like Claude Code for their core system overhauls.
Ad
IBM Stock: New Analysis - 26 February
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis IBM Aktien ein!
Für. Immer. Kostenlos.

